Phenotypic Precision Medicine in Advanced Prostate Cancer

Novel PRO Tool for Patients With Prostate Cancer After Radionuclide Therapy
Moffitt Cancer Center researchers have developed the first patient-reported outcome (PRO) measure for patients receiving radionuclide therapy (RNT) to guide treatment and improve quality of care. Lisa M. Gudenkauf, PhD, and colleagues published their findings in The Journal of Nuclear Medicine. ...
Advertisement

Latest News

Advertisement

Video Interviews

Prostate Cancer Knowledge Hubs

Curated clinical content on prostate cancer types, therapies, and technologies

Prostate Cancer
Prostate Cancer

Conference Coverage

Advertisement
Advertisement
Trending